Amgen Inc. is a leading biotechnology company dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. The company's mission is to serve patients by transforming the promise of science and biotechnology into therapies that have the potential to treat serious illnesses. Amgen's strategy focuses on leveraging its advanced research capabilities and strong pipeline of biologic medicines to address unmet medical needs in areas such as oncology, cardiovascular disease, and inflammation. With a commitment to quality and sustainability, Amgen operates globally, ensuring access to its life-changing therapies for patients around the world.

AMGEN INC

Amgen continues to be a prominent player in the biotechnology sector, with notable engagements this month. On February 19, 2025, the company will present at Citi's 2025 Virtual Oncology Leadership Summit. Jean-Charles Soria, the senior vice president of oncology, will share insights into Amgen’s evolving oncology pipeline and advancements. This presentation marks a significant opportunity for investors and stakeholders to gain a deeper understanding of Amgen’s commitment to oncology therapeutics.

Additionally, Amgen recently participated in the 35th Annual Oppenheimer Healthcare Life Sciences Conference on February 12, 2025. The conference featured Narimon Honarpour, senior vice president of global development, and was accessible for media coverage as well as investors and the public, emphasizing transparency and engagement.

Amgen has been recognized for its innovation and workplace culture; in 2024, it was celebrated as one of the "World's Most Innovative Companies" and "America's Best Large Employers." The company has a long-standing history, spanning over 40 years, dedicated to developing impactful medicines for serious diseases. It maintains a strong position in the market as a member of the Dow Jones Industrial Average and the Nasdaq-100 Index, reflecting its stability and significance within the industry.

As investors look ahead, keeping an eye on Amgen's oncology advancements and corporate engagements could present valuable insights into the company’s strategy and potential growth in the biopharmaceutical landscape. More information and updates can be accessed through Amgen's official website.

one of the "World's Most Innovative Companies"

member of the Dow Jones Industrial Average and the Nasdaq-100 Index

Amgen to Showcase Innovation and Oncology Advancements at Upcoming Industry Conferences in 2025

Amgen is set to highlight its oncology innovations at key industry conferences this month, showcasing its evolving pipeline and commitment to impactful therapeutics. With a legacy of over 40 years in biotechnology, can Amgen's advancements continue to drive growth in an ever-changing market?